Abstract:A series of six pyrimidine-modified dNTPs--5-ethynyl-, 5-phenyl-, and 5-(3-nitrophenyl)deoxycitidine and -deoxyuridine triphosphates--were prepared and incorporated by primer extension with Vent (exo-)polymerase to specific DNA sequences within or next to the recognition sequences of selected restriction endonucleases. The cleavage of these pyrimidine-modified DNA sequences by 13 restriction enzymes was then studied. Whereas the presence of any modified C within the target sequence completely prevented any res… Show more
“…Nucleophilic substitution with sodium azide [34] followed by reactionw ith 2-chloroethanesulfonyl chloride affordedt he desired compound 3 in acceptabley ield (34 %o vert wo steps). [36,37] Therefore, the study required the preparation of 2'-deoxycytidine triphosphates that contained an alkyne moiety at position 5( dC E TP and dC O TP)a ss ubstrates for the polymerase synthesis of alkyne-modified DNA. [36,37] Therefore, the study required the preparation of 2'-deoxycytidine triphosphates that contained an alkyne moiety at position 5( dC E TP and dC O TP)a ss ubstrates for the polymerase synthesis of alkyne-modified DNA.…”
N-(3-Azidopropyl)vinylsulfonamide was developed as a new bifunctional bioconjugation reagent suitable for the cross-linking of biomolecules through copper(I)-catalyzed azide-alkyne cycloaddition and thiol Michael addition reactions under biorthogonal conditions. The reagent is easily clicked to an acetylene-containing DNA or protein and then reacts with cysteine-containing peptides or proteins to form covalent cross-links. Several examples of bioconjugations of ethynyl- or octadiynyl-modified DNA with peptides, p53 protein, or alkyne-modified human carbonic anhydrase with peptides are given.
“…Nucleophilic substitution with sodium azide [34] followed by reactionw ith 2-chloroethanesulfonyl chloride affordedt he desired compound 3 in acceptabley ield (34 %o vert wo steps). [36,37] Therefore, the study required the preparation of 2'-deoxycytidine triphosphates that contained an alkyne moiety at position 5( dC E TP and dC O TP)a ss ubstrates for the polymerase synthesis of alkyne-modified DNA. [36,37] Therefore, the study required the preparation of 2'-deoxycytidine triphosphates that contained an alkyne moiety at position 5( dC E TP and dC O TP)a ss ubstrates for the polymerase synthesis of alkyne-modified DNA.…”
N-(3-Azidopropyl)vinylsulfonamide was developed as a new bifunctional bioconjugation reagent suitable for the cross-linking of biomolecules through copper(I)-catalyzed azide-alkyne cycloaddition and thiol Michael addition reactions under biorthogonal conditions. The reagent is easily clicked to an acetylene-containing DNA or protein and then reacts with cysteine-containing peptides or proteins to form covalent cross-links. Several examples of bioconjugations of ethynyl- or octadiynyl-modified DNA with peptides, p53 protein, or alkyne-modified human carbonic anhydrase with peptides are given.
“…On the other hand, some less bulky modificationsa re often tolerated at position7 of 7-deazaadenine and at position 5o fu racil. [14][15][16] This might indicatet hat, at least for some REs, the major-grooves pecific recognition of the G:Cp airs might be more important than that of A:Tp airs. However,b ecause even the enzymes that tolerate modifications on Aa nd T do not cleave the sequences with A:Tt oT :A mutation, they still must have other means for the recognitiono fA:T pairs that are not affected by small majorgroove substituents.…”
Section: Study Of the Influence Of Modified Guaniner Esidues Within Rmentioning
confidence: 96%
“…The residue was co-evaporated several times with water.T he product was purified by HPLC chromatography [aq. TEAB ( (100) (16,dG Ac TP):N ucleoside 14 (53 mg, 0.146 mmol) was suspended in trimethyl phosphate (426 mL) in an argonpurged vial, and the suspension was cooled to 0 8C. Then, non-redistilled POCl 3 (20 mL, 0.215 mmol) was added.…”
Previous studies of polymerase synthesis of base-modified DNAs and their cleavage by restriction enzymes have mostly related only to 5-substituted pyrimidine and 7-substituted 7-deazaadenine nucleotides. Here we report the synthesis of a series of 7-substituted 7-deazaguanine 2'-deoxyribonucleoside 5'-O-triphosphates (dG(R) TPs), their use as substrates for polymerase synthesis of modified DNA and the influence of the modification on their cleavage by type II restriction endonucleases (REs). The dG(R) TPs were generally good substrates for polymerases but the PCR products could not be visualised on agarose gels by intercalator staining, due to fluorescence quenching. The presence of 7-substituted 7-deazaguanine residues in recognition sequences of REs in most cases completely blocked the cleavage.
“…The incorporation of 7-deazaA was used [3] as a means of permanently protecting DNA against cleavage by certain REs. Recently, we reported a systematic study of the cleavage of DNA containing 7-substituted 7-deazaadenines [4] and 5-substituted pyrimidines; [5] we found a surprising tolerance of several REs to the presence of not only 7-deazaadenine but also some 7-substituted derivatives. In these studies, [4,5] permanent protection against cleavage by REs was also demonstrated.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.